MISSISSAUGA, ON, Aug. 1, 2024 /CNW/ – Cipher Pharmaceuticals Inc. CPH CPHRF (“Cipher” or the “Company“) today announced that it will release its financial results for the second quarter of 2024 after the market close on Thursday, August 8, 2024. The Company will also hold a conference call on Friday, August 9, 2024 at 8:30AM ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
|
DATE: |
August 9, 2024 |
|
TIME: |
8:30AM |
|
DIAL-IN NUMBER: |
(+1) 437-900-0527 or 888-510-2154 |
|
REPLAY: |
(+1) 289-819-1450 or 888-660-6345 Code: 28622# |
|
Expires: August 16, 2024 |
|
|
WEBCAST: |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals CPH CPHRF is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/August2024/01/c9842.html
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
